Effects of vitamin D supplementation on metabolic parameters in women with polycystic ovary syndrome: a randomized controlled trial
Authors:
Open Access
- 16 July 2024
- journal article
- research article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 17 (1) , 1-10
Abstract
Objective: The aim of this study was to explore the effects of vitamin D supplementation on metabolic parameters in women with polycystic ovary syndrome (PCOS). Methods: A total of 60 PCOS women with vitamin D deficiency or insufficiency were enrolled in this randomized controlled trial. Participants were randomized to vitamin D group (2000 IU/day) or control group. The observational parameters were measured at baseline and after treatment, including body mass index (BMI), waist to hip ratio (WHR), oral glucose tolerance test (OGTT) and insulin release test, and lipid metabolism parameters. Results: The serum 25(OH)D concentrations at different time points after vitamin D supplementation were significantly higher than that in control group (P < 0.05). The BMI, WHR, insulin concentrations, homeostasis model assessment of insulin resistance (HOMA-IR), triglycerides (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) concentrations in women of Vitamin D group after 12 weeks of treatment were significantly lower than that in women of control group (P < 0.05). The serum insulin concentrations and HOMA-IR at different time points of OGTT, serum TG, TC and LDL-C concentrations in women of vitamin D group (obesity) were significantly lower compared with control group (obesity) (P < 0.05). The BMI, WHR, TG, TC and LDL-C concentration in women of vitamin D group (IR) were significantly lower compared with control group (IR) (P < 0.05). No significant difference was observed in metabolic parameters between vitamin D group (non-obesity) and control group (non-obesity) (P > 0.05), and these differences of metabolic parameters were also not observed between vitamin D group (non-IR) and control group (non-IR) (P > 0.05). Conclusion: Vitamin D supplementation had beneficial effects on metabolic parameters in PCOS women, especially in women with obesity or insulin resistance.Keywords
All Related Versions
Funding Information
- The Social Development Project of Key Research and Development Program of Shaanxi Province, China (No. 2022SF-163)
This publication has 35 references indexed in Scilit:
- Effect of sumac powder on clinical symptoms, hyperandrogenism, inflammation, blood glucose, lipid profiles in women with polycystic ovary syndrome: A double‐blind randomized clinical trialPhytotherapy Research, 2023
- Nonalcoholic fatty liver disease in women with polycystic ovary syndromeEndocrine, 2019
- Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in MiceHepatology, 2019
- Evaluation of vitamin D3 deficiency: A population‐based study in northeastern IranJournal of Cellular Biochemistry, 2018
- Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trialEuropean Journal of Nutrition, 2018
- Vitamin D Switches BAF Complexes to Protect β CellsCell, 2018
- Study of Effect of Vitamin D Supplementation on the Clinical, Hormonal and Metabolic Profile of the PCOS WomenThe Journal of Obstetrics and Gynecology of India, 2017
- Vitamin D Metabolite, 25-Hydroxyvitamin D, Regulates Lipid Metabolism by Inducing Degradation of SREBP/SCAPCell Chemical Biology, 2017
- Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndromeClinical Nutrition, 2015
- Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulatorsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008